Interestingly, a few years before Kelly et al.’s study, Braak’s group had already shown that decades before the onset of the first clinical signs of AD, there is already an accumulation of abnormal proteins—specifically hyperphosphorylated tau protein (pTau)—in the cell bodies and later in the axon terminals of LC neurons [85]. The gene discussed is MAPT; the disease is Alzheimer disease.